α-secretase ADAM10 as well as αAPPs is reduced in platelets and CSF of Alzheimer disease patients

Molecular Medicine

Volumn 8, Issue 2, 2002, Pages 67-74

  Colciaghi, Francesca ^a   Borroni, Barbara ^a   Pastorino, Lucia ^a   Marcello, Elena ^a   Zimmermann, Martina ^a   Cattabeni, Flaminio ^a   Padovani, Alessandro ^a   Di Luca, Monica ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SECRETASE; AMYLOID PRECURSOR PROTEIN; ANTIBODY; ISOPROTEIN; METALLOPROTEINASE; METALLOPROTEINASE ADAM 10; THROMBIN; UNCLASSIFIED DRUG;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; ENZYME RELEASE; FEMALE; HUMAN; HUMAN CELL; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; THROMBOCYTE ACTIVATION; WESTERN BLOTTING;

EID: 0036042518     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03402076     Document Type: Article

References (32)

1. Beta-amyloid precursor protein cleavage by a membrane-bound protease
2. Cleavage of Alzheimer's amyloid precursor protein (APP) by secretases occurs after O-glycosylation of APP in the protein secretory pathway - Identification of intracellular compartment in which APP cleavage occurs without using toxic agents that interfere with protein metabolism
3. Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein
4. Cellular processing of beta-amyloid precursor protein and the genesis of amyloid beta-peptide
5. Ectodomain phosphorylation of beta-amyloid precursor protein at two distinct cellular locations
6. Evidence that tumor necrosis factor alpha-converting enzyme is involved in regulated alpha-secretase cleavage of the Alzheimer amyloid precursor protein
7. Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors
8. Membrane-anchored metalloprotease MDC9 has an alpha-secretase activity responsible for processing the amyloid precursor protein
9. Evidence for an interaction of the metalloprotease-disintegrin tumor necrosis factor alpha convertase (TACE) with mitotic arrest deficient 2 (MAD2), and of the metalloprotease-disintegrin MDC9 with a novel MAD2-related protein, MAD2beta
10. Constitutive and regulated α-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease
11. Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the α-secretase
12. Constitutive shedding of the amyloid precursor protein ectodomain is up-regulated by tumour necrosis factor-alpha converting enzyme
13. Alzheimer's amyloid precursor protein alpha-secretase is inhibited by hydroxamic acid-based zinc metalloprotease inhibitors: Similarities to the angiotensin converting enzyme secretase
14. Abnormal pattern of platelet APP isoforms in Alzheimer disease and Down syndrome
15. Moderate and advanced Alzheimer's patients exhibit platelet activation differences
16. Activated Alzheimer disease platelets retain more beta amyloid precursor protein
17. Altered amyloid protein processing in platelets of patients with Alzheimer disease
18. Alzheimer disease-related abnormalities of amyloid beta precursor protein isoforms in the platelets - The brain delegates in the periphery?
19. Differential pattern of platelet APP isoforms: An early marker for Alzheimer disease
20. Platelet APP isoform ratios correlate with declining cognition in AD
21. Amyloid precursor protein in platelets of patients with Alzheimer disease - Effect of acetylcholinesterase inhibitor treatment
22. Amyloid precursor protein in platelets: A peripheral marker for the diagnosis of sporadic AD
23. Protease nexin II (amyloid beta protein precursor): A platelet α-granule protein
24. Secretion of Alzheimer's disease A beta amyloid peptide by activated human platelets
25. Platelets and DAMI megakaryocytes possess beta-secretase-like activity
26. The amyloid precursor protein of Alzheimer's disease is released by human platelets
27. Decreased alpha-secretase-cleaved amyloid precursor protein as a diagnostic marker for Alzheimer's disease
28. Cerebrospinal fluid levels of alpha-secretase-cleaved soluble amyloid precursor protein mirror cognition in a Swedish family with Alzheimer disease and a gene mutation
29. Levels of α and β secretase cleaved amyloid precursor protein in the cerebrospinal fluid of Alzheimer's disease patients
30. Coordinated expression of β-amyloid precursor protein and putative β-secretase BACE and α-secretase ADAM10 in mouse and human brain
31. Amyloid precursor protein and amyloid b peptide in human platelets
32. L. glutamate uptake is decreased in platelets from Alzheimer's disease patients